ubuvuzi busobanutse kanseri yimpyiko kanseri

Kuvura kanseri yimpyiko isukuye kanseri: Ubuyobozi bwuzuyeGusobanukirwa uburyo bwo kuvura kanseri yimpyiko zanduye (ccRCC) ningirakamaro kubarwayi nimiryango yabo. Aka gatabo gatanga incamake yuburyo bwo kuvura ubu, byibanda kubikorwa bishingiye ku bimenyetso no kwita ku barwayi. Tuzasesengura ibyiciro bitandukanye bya ccRCC hamwe nubuvuzi bwihariye bukoreshwa kuri buri cyiciro, tugaragaza akamaro ko kwisuzumisha hakiri kare no gucunga neza. Aya makuru agamije uburezi kandi ntagomba gufatwa nkinama zubuvuzi. Buri gihe ujye inama ninzobere mu buvuzi kuri gahunda yo kuvura yihariye.

Gusuzuma no Gutunganya ccRCC

Gusuzuma neza no gutunganya nibyingenzi muguhitamo ingamba zifatika zo kuvura selile selile yimpyiko kanseri. Ubuhanga bwo gufata amashusho, nka CT scan na MRI, nibyingenzi mukumenya ubunini bwikibyimba, aho giherereye, nibishobora gukwirakwira. Biopsies ikorwa kenshi kugirango hemezwe isuzuma no kumenya ubwoko bwihariye bwa kanseri yimpyiko, harimo na ccRCC. Sisitemu yo kubika, nka sisitemu yo kubika TNM, itondekanya urugero rwa kanseri, bigira ingaruka kumyemezo yo kuvura. Kumenya hakiri kare, binyuze mugupima buri gihe no gukora iperereza ryihuse ryibimenyetso, bitezimbere cyane.

Gusobanukirwa Sisitemu yo Kubika TNM

Sisitemu yo kubika TNM ikoresha ibintu bitatu kugirango ishyire mubikorwa selile selile yimpyiko kanseri: T: Dondora ingano nubunini bwikibyimba cyibanze. N: Yerekana uruhare rwa lymph node hafi. UMWIGISHA: Kugaragaza niba kanseri yarahinduye (ikwirakwira) mu ngingo za kure.Buri kimwe muri ibyo bintu cyakira icyiciro (urugero, T1, T2, nibindi), gitanga isuzuma ryuzuye ryerekana uko indwara igenda. Ihuriro rya T, N, na M ritanga icyiciro rusange cya kanseri.

Amahitamo yo kuvura kuri ccRCC

Uburyo bwo kuvura selile selile yimpyiko kanseri zitandukanye cyane ukurikije icyiciro cya kanseri nubuzima bwumurwayi muri rusange. Kubaga kubaga nubuvuzi bwibanze bwa ccRCC yaho, mugihe ubuvuzi bwa sisitemu, harimo nubuvuzi bugamije hamwe nubudahangarwa bw'umubiri, bukunze gukoreshwa kuburwayi bwateye imbere cyangwa metastatike.

Kubaga

Kubireba selile selile yimpyiko kanseri, kubaga kuvanaho ikibyimba kandi birashoboka igice cyangwa impyiko zose zanduye (nephrectomy igice cyangwa nephrectomy radical) mubisanzwe umurongo wambere wubuvuzi. Guhitamo hagati yubu buryo biterwa nibintu byinshi, harimo ubunini bwikibyimba, aho giherereye, nubuzima bwumurwayi muri rusange. Ubuhanga bwo kubaga byibuze, nko kubaga laparoskopi, biragenda bikundwa, bigabanya igihe cyo gukira nibibazo bishobora kuvuka.

Ubuvuzi bugamije

Ubuvuzi bugamije gukora buhagarika molekile zihariye zigira uruhare mu mikurire yikibyimba. Ubuvuzi butandukanye bugamije kwerekana ko bugira ingaruka nziza selile selile yimpyiko kanseri, cyane cyane izibanda kumitsi ikura (VEGF) hamwe ninyamabere yibasira rapamycine (mTOR). Ingero zirimo sunitinib, sorafenib, pazopanib, na everolimus. Iyi miti irashobora gutangwa kumunwa kandi ikoreshwa kenshi nkumurongo wa mbere cyangwa umurongo wa kabiri wo kuvura ccRCC metastatike. Ingaruka zo kuruhande zirasanzwe kandi zirashobora gutandukana kubantu. Oncologue wawe azagukurikirana neza mugihe cyo kuvura.

Immunotherapy

Immunotherapy ikoresha imbaraga z'umubiri zo kurwanya kanseri. Inzitizi za bariyeri, nka nivolumab na ipilimumab, zifunga ibirindiro by’ubudahangarwa, bituma sisitemu y’umubiri imenya kandi ikanatera kanseri neza. Iyi miti ikoreshwa kenshi murwego rwo hejuru cyangwa metastatike selile selile yimpyiko kanseri kandi irashobora guhuzwa nubuvuzi bugamije ibisubizo byiza. Immunotherapy irashobora gutanga ingaruka zikomeye, harimo na autoimmune ingorane, zishobora gusaba ubuvuzi hafi.

Ubuvuzi

Nubwo atari ubuvuzi bwibanze bwa ccRCC, imiti ivura imirasire irashobora kugira uruhare runini mugucunga ububabare buterwa namagufwa cyangwa kuvura indwara zisubirwamo nyuma yo kubagwa.

Ibigeragezo bya Clinical

Abarwayi hamwe selile selile yimpyiko kanseri igomba gutekereza kwitabira ibizamini byamavuriro. Igeragezwa rya Clinical ritanga uburyo bushya bwo kuvura kandi bugira uruhare mu guteza imbere ubushakashatsi bwa kanseri. Muganga wawe arashobora kugufasha mugushakisha amahirwe akwiye yo kwipimisha. Ikigo cyubushakashatsi bwa Kanseri ya Shandong Baofa https://www.baofahospital.com/ yitangiye gutanga ubuvuzi bwa kanseri igezweho kandi ikora ubushakashatsi yibanda ku kuzamura umusaruro w'abarwayi.

Gukurikirana no gukurikirana

Nyuma yo kuvurwa, gahunda yo gukurikirana buri gihe ningirakamaro mugukurikirana ibisubirwamo cyangwa ikibyimba gishya. Kwiga amashusho no gupima amaraso bikoreshwa kenshi mugukurikirana indwara. Kumenya hakiri kare ibyasubiwemo bituma habaho gutabara byihuse kandi birashobora kunoza ibisubizo.

Ubwoko bwo kuvura	Urwego	Icyiciro cya ccRCC	Ingaruka Zisanzwe Zuruhande
Kubaga	Gukuraho ikibyimba kumubiri	CcRCC	Kubabara, kwandura, kuva amaraso
Ubuvuzi bugamije	Kubuza molekile zihariye	CcRCC	Umunaniro, isesemi, hypertension
Immunotherapy	Gukangura sisitemu yumubiri	CcRCC	Umunaniro, kurwara uruhu, ibibazo bya autoimmune

Inshingano: Aya makuru agamije uburezi gusa kandi ntagomba gufatwa nkinama zubuvuzi. Buri gihe ujye ubaza inzobere mu by'ubuzima zujuje ibisabwa kugira ngo zisuzume kandi zivure indwara iyo ari yo yose.